Maravai Lifesciences Holdings (MRVI) Net Cash Flow (QoQ) (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.02% |
| Dec 31, 2025 | -1.42% |
| Sep 30, 2025 | -75.09% |
| Jun 30, 2025 | 59.82% |
| Mar 31, 2025 | 85.37% |
| Dec 31, 2024 | -5,229.52% |
| Sep 30, 2024 | -56.57% |
| Jun 30, 2024 | 186.50% |
| Mar 31, 2024 | -185.83% |
| Dec 31, 2023 | -713.13% |
| Sep 30, 2023 | 98.81% |
| Jun 30, 2023 | -1,144.42% |
| Mar 31, 2023 | -126.31% |
| Dec 31, 2022 | -78.00% |
| Sep 30, 2022 | -43.99% |
| Jun 30, 2022 | 199.50% |
| Mar 31, 2022 | -3,516.11% |
| Dec 31, 2021 | -97.97% |
| Sep 30, 2021 | 35.85% |
| Jun 30, 2021 | 1,008.32% |